Wang Kevin Y, Newman James, Lee Chung-Shien, Seetharamu Nagashree
Department of Internal Medicine, Northshore University Hospital, Manhasset, NY, USA.
Department of Hematology Oncology, Northshore University Hospital, Manhasset, NY, USA.
SAGE Open Med. 2021 May 25;9:20503121211017757. doi: 10.1177/20503121211017757. eCollection 2021.
Breast cancer is the most common malignancy in women, and lung cancer, the leading cause of cancer-related mortality in the United States, is the most common subsequent primary cancer among breast cancer survivors. In this review, we examine the risk factors that cause subsequent primary lung cancer after breast cancer (referred to herein as BCLC patients) as well as the prognostic factors that may affect survival. Notable clinicopathological features include patient characteristics such as age, smoking history, and the presence of or mutations, as well as factors related to the treatment of breast cancer such as radiation, surgery, chemotherapy, stage, anti-estrogen therapy, and ER/PR/HER2 status.
乳腺癌是女性中最常见的恶性肿瘤,而肺癌是美国癌症相关死亡的主要原因,是乳腺癌幸存者中最常见的后续原发性癌症。在本综述中,我们研究了导致乳腺癌后发生后续原发性肺癌的风险因素(本文中称为BCLC患者)以及可能影响生存的预后因素。显著的临床病理特征包括患者特征,如年龄、吸烟史以及 或 突变的存在,以及与乳腺癌治疗相关的因素,如放疗、手术、化疗、分期、抗雌激素治疗和ER/PR/HER2状态。